36F79720D0180 - 65 I B, DRUGS, PHARMACEUTICALS,&HEMATOLOGY REL...
Federal Contract Award Search » FSS Award - Pharmaceuticals and Drugs
This FSS contract for Healthcare > Medical Practitioners, Pharmaceuticals > Pharmaceutical Products was awarded in FY2020 on Jul 30, 2020 to NOVARTIS PHARMACEUTICALS CORPORATION by National Acquisition Center. There have been $23.2M in obligations to date with a ceiling value of $5.4B, showing a 0% burn rate so far on the contract. The contract was not competed under any preference program with 999 offers received. We expect a 10 year duration with ultimate completion date of Sep 29, 2030.
NOVARTIS PHARMACEUTICALS CORPORATION is a contractor located in NJ, doing primarily Pharmaceuticals > Pharmaceutical Products work for Veterans Affairs. The company receives $7.8M annually in federal awards (as of FY2020). Also, they have shown success winning No/Limited Bias contracts concentrated mainly on a singular customer focused portfolio.
The General Services Administration (GSA), the central acquisition entity within the Federal Government, manages a catalog of Multiple Award Schedules (MAS). The GSA uses MAS to establish lines of business or cohorts of contractors grouped by similar goods and services. Schedules are open to all government customers and provide a streamlined process to procure various professional services, IT services, and products, ranging from cars to hardware.
- Contract Number
- 36F79720D0180
- Contractor
- NOVARTIS PHARMACEUTICALS CORPORATION
- Obligations to Date
- $23.2M
- Ceiling Value
- $5.4B
- Award Date
- 07/30/2020
- Contract Type
- FSS
- Contract Vehicle
- Pharmaceuticals and Drugs
- Competition Set Aside Type
- No set aside used
- Buying Agency/Office
- Veterans Affairs»VA Office of Acquisition, Logistics and Construction»Office of Procurement, Acquisition and Logistics»National Acquisition Center
Win More Federal Business
Imagine a world where every report, every insight is tailored specifically to you. Our entire platform is configured around your past performance so that everything is relevant.
All the Right Tools
Business Development & Pipeline Management
We start with the largest federal opportunity database, including forecasts and re-competes, and add layer a suite of pipeline management tools.
Personalized Markets
Our market-centric platform adds context to every pursuit. Every opportunity, every report, tailored specifically to you.
Award Research & Market Intelligence
Find gaps in the market, identify key competitors and teaming partners, evaluate performance, and analyze pathways to new business.
Start Your Free Account Today
That's right. It's free to get started with Federal Compass
Gain Full Access to This Report and...
Contract Opportunities
Pipeline Management
Award Research
Funding Analysis
Partner Identification
Industry and Market Intel
Agency Spending Trends
Competitive Insights
Enjoy instant access to the Federal Compass platform
Task Order History
| Task Order No. | Contractor | Obligations | Effective Date |
|---|---|---|---|
| 36C25721N0069 | NOVARTIS PHARMACEUTICALS CORPORATION | $283.5k | 10/22/2020 |
| 36C24921N0177 | NOVARTIS PHARMACEUTICALS CORPORATION | $283.5k | 11/05/2020 |
| 36C24921N0254 | NOVARTIS PHARMACEUTICALS CORPORATION | $283.5k | 12/16/2020 |
| 36C24921N0300 | NOVARTIS PHARMACEUTICALS CORPORATION | $283.6k | 01/12/2021 |
| 36C24921N0323 | NOVARTIS PHARMACEUTICALS CORPORATION | $283.6k | 01/26/2021 |
| 36C24921N0367 | NOVARTIS PHARMACEUTICALS CORPORATION | $283.6k | 03/08/2021 |
| 36C25622N0408 | NOVARTIS PHARMACEUTICALS CORPORATION | $0.04 | 12/16/2021 |
| 36C25025F0384 | NOVARTIS PHARMACEUTICALS CORPORATION | $598.1k | 02/05/2025 |
| 36C25025F0386 | NOVARTIS PHARMACEUTICALS CORPORATION | $0.00 | 02/06/2025 |
| 36C25725N0190 | NOVARTIS PHARMACEUTICALS CORPORATION | $4.1M | 02/07/2025 |
| 36C24525N0473 | NOVARTIS PHARMACEUTICALS CORPORATION | $33.8k | 03/14/2025 |
| 36C24525N0558 | NOVARTIS PHARMACEUTICALS CORPORATION | $33.8k | 04/11/2025 |
| 36C24525N0655 | NOVARTIS PHARMACEUTICALS CORPORATION | $33.8k | 05/27/2025 |
| 36C25725N0376 | NOVARTIS PHARMACEUTICALS CORPORATION | $432k | 06/16/2025 |
| 36C24525N0724 | NOVARTIS PHARMACEUTICALS CORPORATION | $33.8k | 06/18/2025 |
| 36C24525N0864 | NOVARTIS PHARMACEUTICALS CORPORATION | $33.8k | 08/04/2025 |
| 36C25025F0747 | NOVARTIS PHARMACEUTICALS CORPORATION | $170k | 08/05/2025 |
| 36C25025F0726 | NOVARTIS PHARMACEUTICALS CORPORATION | $400.2k | 08/05/2025 |
| 36C25225N0482 | NOVARTIS PHARMACEUTICALS CORPORATION | $297.5k | 08/07/2025 |
| 36C25525N0396 | NOVARTIS PHARMACEUTICALS CORPORATION | $736.6k | 08/11/2025 |
